Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass

Xin-Ping Yu; Ying Liu; Jin-Wen Jiao; Hong-Juan Yang; Rui-Jing Wang; Shuai Zhang

doi:10.12659/MSM.924497

17 August 2020 : Clinical Research

Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass

Xin-Ping Yu^1BCE, Ying Liu^2C, Jin-Wen Jiao^1D, Hong-Juan Yang^1B, Rui-Jing Wang^1D, Shuai Zhang^3ACF*

DOI: 10.12659/MSM.924497

Med Sci Monit 2020; 26:e924497

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Receiver operating characteristic curves for age, CA125, HE4, maximum thickness of wall, maximum thickness of septa, maximum diameter of solid component and combination of age, vascular abnormalities and maximum diameter of solid component in differentiating SBOTs and SMOTs. CA125 – cancer antigen 125; HE4 – human epididymis protein 4; SBOTs – serous borderline ovarian tumors; SMOTs – serous malignant ovarian tumors.

Back to the Article

Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass

Your Privacy